Over the past decade, biomedical prevention interventions—including voluntary medical male circumcision (VMMC) and oral pre-exposure prophylaxis (PrEP)—have resulted in substantial gains in controlling the global HIV epidemic. Despite the inclusion of these highly effective interventions in multinational strategies and global prevention toolkits, their effective implementation rests upon context-specific, data-driven delivery to priority populations and geographies. Project SOAR has contributed to the evidence base by increasing access to and use of data through user-friendly interfaces and dissemination strategies, advancing VMMC and PrEP as vital prevention interventions in the global discourse. SOAR’s biomedical prevention portfolio has ...
Project SOAR, led by the Population Council, in partnership with the Center of Reproductive Health a...
The global HIV response has entered a new phase with the recommendation of treating all persons livi...
BACKGROUND: HIV remains the largest cause of disease burden among men and women of reproductive age ...
Project SOAR has developed an extensive voluntary medical male circumcision (VMMC) portfolio to supp...
Defining the HIV prevention and treatment needs of key populations who have disproportionate HIV acq...
The Population Council, with funding from the Bill & Melinda Gates Foundation and the US Agency for ...
Few programs intended to improve HIV outcomes or modulate gender norms have been rigorously evaluate...
Despite the availability of life-saving treatment for HIV, several barriers prevent patient access t...
BACKGROUND: The HIV treatment cascade illustrates the steps required for successful treatment and is...
Project SOAR is conducting implementation science research in Malawi to build needed evidence to inf...
SummaryBackgroundThe HIV treatment cascade illustrates the steps required for successful treatment a...
HIV testing is a critical entry point to life-saving antiretroviral therapy (ART) for those diagnose...
The Population Council, with funding from Girl Effect, worked in seven Determined, Resilient, Empowe...
Background: Evidence of HIV drug resistance (HIVDR) in individuals using oral pre-exposure prophylax...
Many adolescent girls and young women (AGYW) lack opportunities and access to resources, and experie...
Project SOAR, led by the Population Council, in partnership with the Center of Reproductive Health a...
The global HIV response has entered a new phase with the recommendation of treating all persons livi...
BACKGROUND: HIV remains the largest cause of disease burden among men and women of reproductive age ...
Project SOAR has developed an extensive voluntary medical male circumcision (VMMC) portfolio to supp...
Defining the HIV prevention and treatment needs of key populations who have disproportionate HIV acq...
The Population Council, with funding from the Bill & Melinda Gates Foundation and the US Agency for ...
Few programs intended to improve HIV outcomes or modulate gender norms have been rigorously evaluate...
Despite the availability of life-saving treatment for HIV, several barriers prevent patient access t...
BACKGROUND: The HIV treatment cascade illustrates the steps required for successful treatment and is...
Project SOAR is conducting implementation science research in Malawi to build needed evidence to inf...
SummaryBackgroundThe HIV treatment cascade illustrates the steps required for successful treatment a...
HIV testing is a critical entry point to life-saving antiretroviral therapy (ART) for those diagnose...
The Population Council, with funding from Girl Effect, worked in seven Determined, Resilient, Empowe...
Background: Evidence of HIV drug resistance (HIVDR) in individuals using oral pre-exposure prophylax...
Many adolescent girls and young women (AGYW) lack opportunities and access to resources, and experie...
Project SOAR, led by the Population Council, in partnership with the Center of Reproductive Health a...
The global HIV response has entered a new phase with the recommendation of treating all persons livi...
BACKGROUND: HIV remains the largest cause of disease burden among men and women of reproductive age ...